A detailed history of Klingenstein Fields & CO LP transactions in Abbott Laboratories stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 127,401 shares of ABT stock, worth $14.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
127,401
Previous 127,230 0.13%
Holding current value
$14.6 Million
Previous $13.2 Million 9.86%
% of portfolio
0.58%
Previous 0.55%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$100.07 - $118.13 $17,111 - $20,200
171 Added 0.13%
127,401 $14.5 Million
Q2 2024

Aug 01, 2024

BUY
$100.73 - $112.44 $13,497 - $15,066
134 Added 0.11%
127,230 $13.2 Million
Q1 2024

Apr 29, 2024

SELL
$109.52 - $120.96 $236,453 - $261,152
-2,159 Reduced 1.67%
127,096 $14.4 Million
Q4 2023

Feb 01, 2024

SELL
$90.19 - $110.4 $217,808 - $266,616
-2,415 Reduced 1.83%
129,255 $14.2 Million
Q3 2023

Oct 27, 2023

SELL
$95.53 - $114.62 $15,475 - $18,568
-162 Reduced 0.12%
131,670 $12.8 Million
Q2 2023

Aug 01, 2023

SELL
$100.78 - $112.29 $209,622 - $233,563
-2,080 Reduced 1.55%
131,832 $14.4 Million
Q1 2023

Apr 28, 2023

BUY
$96.86 - $114.01 $131,439 - $154,711
1,357 Added 1.02%
133,912 $13.6 Million
Q4 2022

Feb 02, 2023

BUY
$95.06 - $111.52 $14,829 - $17,397
156 Added 0.12%
132,555 $14.6 Million
Q3 2022

Oct 28, 2022

BUY
$96.76 - $112.03 $164,782 - $190,787
1,703 Added 1.3%
132,399 $12.8 Million
Q2 2022

Aug 01, 2022

SELL
$102.07 - $123.37 $107,479 - $129,908
-1,053 Reduced 0.8%
130,696 $14.2 Million
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $38,538 - $46,995
338 Added 0.26%
131,749 $15.6 Million
Q4 2021

Jan 31, 2022

SELL
$115.53 - $141.46 $183,692 - $224,921
-1,590 Reduced 1.2%
131,411 $18.5 Million
Q3 2021

Oct 26, 2021

SELL
$116.66 - $129.06 $346,596 - $383,437
-2,971 Reduced 2.19%
133,001 $15.7 Million
Q2 2021

Jul 26, 2021

SELL
$105.79 - $124.53 $421,255 - $495,878
-3,982 Reduced 2.85%
135,972 $15.8 Million
Q1 2021

Apr 29, 2021

BUY
$108.84 - $128.23 $28,080 - $33,083
258 Added 0.18%
139,954 $16.8 Million
Q4 2020

Feb 02, 2021

BUY
$105.0 - $114.42 $160,860 - $175,291
1,532 Added 1.11%
139,696 $15.3 Million
Q3 2020

Oct 30, 2020

SELL
$91.64 - $111.29 $103,644 - $125,868
-1,131 Reduced 0.81%
138,164 $15 Million
Q2 2020

Aug 03, 2020

BUY
$76.57 - $98.0 $749,850 - $959,714
9,793 Added 7.56%
139,295 $12.7 Million
Q1 2020

May 07, 2020

BUY
$62.82 - $91.86 $44,602 - $65,220
710 Added 0.55%
129,502 $10.2 Million
Q4 2019

Feb 04, 2020

SELL
$78.51 - $87.4 $84,712 - $94,304
-1,079 Reduced 0.83%
128,792 $11.2 Million
Q3 2019

Nov 01, 2019

SELL
$81.84 - $88.74 $210,656 - $228,416
-2,574 Reduced 1.94%
129,871 $10.9 Million
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $505,787 - $589,900
6,940 Added 5.53%
132,445 $11.1 Million
Q1 2019

Apr 29, 2019

BUY
$66.22 - $80.06 $1.87 Million - $2.26 Million
28,221 Added 29.01%
125,505 $10 Million
Q4 2018

Jan 22, 2019

BUY
$65.56 - $74.27 $510,056 - $577,820
7,780 Added 8.69%
97,284 $7.04 Million
Q3 2018

Nov 01, 2018

BUY
$60.81 - $73.36 $3.35 Million - $4.05 Million
55,148 Added 160.52%
89,504 $6.57 Million
Q4 2017

Jan 30, 2018

SELL
$53.68 - $57.47 $46,701 - $49,998
-870 Reduced 2.47%
34,356 $1.96 Million
Q3 2017

Nov 01, 2017

BUY
$48.06 - $53.64 $1.69 Million - $1.89 Million
35,226
35,226 $1.88 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Klingenstein Fields & CO LP Portfolio

Follow Klingenstein Fields & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.